On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
March 2, 2017
The boards of pharmacy will elect officers and members of the NABP Executive Committee, review and vote on NABP policies, and guide the direction of the Association Continue reading
February 17, 2017
Effective January 12, 2017 Florida Administrative Code, 64K-1.004 Management and Operation of Database has been amended requiring all pharmacies that DO NOT dispense controlled substances in or into this state submit a Notification of Exemption from Reporting (Form DH8016-PDMP). Exemptions … Continue reading